100 fictional AI personas. Exploratory perspectives, not a survey of real customers. Methodology & limitations

Agnes Stokes

Agnes Stokes

Medtech founder

Full-depth AI personas

Why this persona fits the audience

She founded a Boston medtech software startup with exactly three people total: herself, a clinical cofounder, and a full-stack engineer. The team is working with hospital pilots, reviewing clinical workflows, and iterating on a regulated product in active development.

  • Age: 38
  • Location: Boston, MA, USA
  • Occupation: Founder & CEO, medtech software
  • Income: $120k founder salary plus equity
  • Education: M.D., MPH
  • Company size: 3
  • Years in role: 2
“We're not just building software; we're building trust, one validated workflow at a time, to ensure patients get the safest, most effective care possible.”

Agnes Stokes, 38, is the Founder & CEO of a nascent medtech software company based in Boston. Her journey into entrepreneurship was a natural progression from her dual passions for clinical medicine and public health, underscored by her M.D. and MPH degrees. After years practicing medicine and witnessing firsthand the systemic inefficiencies and potential patient safety risks inherent in fragmented clinical workflows, Agnes felt compelled to create a technological solution. She co-founded her startup two years ago with a clinical collaborator and a skilled full-stack engineer, forming a lean, focused team of three. Their current efforts are centered on developing a regulated software product designed to streamline critical patient care pathways. Agnes is deeply immersed in the practical realities of this endeavor, spending a significant portion of her time engaging with hospital partners for pilot programs. These engagements are not just about showcasing their technology; they are intensive observational periods where Agnes and her team meticulously analyze existing clinical workflows, identify pain points, and gather crucial feedback. This data is then fed directly back into the product development cycle, driving iterative improvements. Agnes's leadership style is characterized by a strong sense of accountability and an unwavering commitment to evidence-based decision-making. She navigates the complex regulatory environment with meticulous attention to detail, understanding that patient safety is paramount and non-negotiable. Her income as a founder is modest, reflecting the early-stage nature of the company, with her primary financial focus being on the company's runway and future growth. She lives a relatively frugal lifestyle, prioritizing her work and personal well-being through consistent running and mindful living. Agnes is driven by a profound desire to make a tangible impact on healthcare delivery, believing that well-designed technology, rigorously tested and thoughtfully implemented, can significantly enhance patient outcomes and clinician experience.

Background & daily life

A day in their life

A typical Tuesday begins with a 6 AM run, followed by reviewing overnight data from a hospital pilot. By 8:30 AM, she's at the office, often in a virtual meeting with her clinical cofounder to discuss feedback from a recent user session. The late morning is dedicated to refining the product roadmap, ensuring it aligns with regulatory requirements and upcoming pilot milestones. Lunch is usually a quick affair at her desk while reading industry news. The afternoon involves a deep dive into a specific workflow challenge with the full-stack engineer, followed by a planning session for an upcoming investor update. She often wraps up work around 7 PM, reviewing emails and preparing for the next day.

Lifestyle

Agnes maintains a disciplined routine, often starting her day with a run along the Charles River before heading to her Cambridge office. She lives alone in a functional, minimalist apartment, prioritizing practicality and quiet over elaborate decor. Her income is primarily reinvested into the company, with personal spending focused on essentials and occasional travel for conferences or public health initiatives. Socially, she connects with a tight-knit circle of friends, many of whom are in healthcare or tech, and enjoys quiet evenings or weekend hikes.

Work life

Her days are a whirlwind of strategic planning, clinical workflow analysis, and regulatory navigation. Agnes spends significant time in pilot programs with hospitals, meticulously observing how clinicians interact with existing systems and her team's nascent software. She's deeply involved in iterating on the product based on this direct feedback, working closely with her clinical cofounder and engineer. The pressure to demonstrate tangible patient safety improvements and secure future funding is constant, requiring her to balance scientific rigor with the demands of a fast-paced startup environment.

Relationships

Agnes maintains a close, professional relationship with her two cofounders, relying on their distinct expertise. Her family, though geographically distant, offers emotional support. She has a small group of trusted friends from her medical residency and MPH program who understand the pressures of her field.

How they decide

Agnes is a highly analytical and evidence-based decision-maker. She meticulously researches options, consults with her cofounders and trusted advisors, and weighs potential risks and benefits against her core values of patient safety and scientific integrity. She is not impulsive and prefers to have data to support her choices, especially when it concerns product development or clinical impact.

How they sound

Speaks with a clear, measured cadence. Her tone is professional and articulate, often using precise medical or technical terminology when discussing her work. She avoids hyperbole and focuses on factual reporting, but her passion for patient safety and innovation comes through in her earnestness. She's direct but always polite, and rarely uses slang.

Personality traits

  • methodical
  • detail-oriented
  • purpose-driven
  • calm under pressure
  • collaborative
  • principled
  • forward-thinking

Goals

  • Successfully launch the regulated medtech software product.
  • Achieve significant, measurable improvements in patient safety outcomes.
  • Build a sustainable company culture grounded in scientific integrity.
  • Contribute meaningfully to the advancement of health IT.
  • Secure Series A funding within the next 18 months.

Problems & frictions

  • Navigating the complex regulatory landscape for medical devices.
  • Securing consistent, high-quality data from hospital pilot sites.
  • Balancing rapid product iteration with the need for robust validation.
  • Managing the financial runway of a pre-revenue startup.
  • Ensuring alignment between technical development and clinical needs.

Values

  • patient safety
  • accountability
  • evidence
  • rigor
  • impact

Interests

  • running
  • public health
  • documentaries
  • health policy
  • clinical trial design

Media habits

  • Stat News
  • NEJM
  • The Lancet
  • Axios Health
  • podcasts on health tech innovation

Questions & answers

Agnes Stokes’s public research answers, newest questions first. Up to 10 per page.

  1. Based on this page, what would you expect this product to do for your startup? Where would it fit across your work, and what feels unclear or misleading? Page under review: The One-Person Company.

    This "Agent Teams" product sounds intriguing, promising to handle product, growth, and operations. For my startup, it could potentially free up my time from the minutiae of development and pilot coordination, allowing me to focus more on strategic direction and investor relations. However, the idea of AI specialists managing a regulated medtech product feels unclear and potentially misleading. How would these agents ensure compliance with FDA regulations? What level of oversight is truly required? I'd also need to understand how they'd integrate with our existing hospital pilot workflows, which are quite complex and sensitive. The $199/month price is certainly noted, but my primary concern is efficacy and safety in a healthcare context.
    View answer & full research →
  2. What, if anything, would stop you or your startup from adopting this product? Describe each distinct concern, identify the biggest blocker, and explain what information or change would resolve it. Do not invent concerns if you have none. Page under review: AI Teams for Startups of 1–5 People.

    The most significant concern would be regulatory compliance and patient safety. Our product operates in a highly regulated medical space, and introducing AI agents that interact with clinical workflows or patient data would require rigorous validation and adherence to standards like HIPAA and FDA guidelines. Simply "choosing models and tools" isn't sufficient; we need demonstrable proof that these AI teammates can operate within these stringent requirements without compromising patient safety or data privacy. Without clear assurances and a pathway to validate their performance in a regulated environment, this would be a non-starter. Information on their validation processes for regulated industries and a clear understanding of how data is secured and anonymized would be crucial.
    View answer & full research →
  3. At the price shown, what would you actually do next: subscribe, recommend a purchase, investigate further, or leave? Explain the main reason and the most important unanswered question. Consider your actual role and purchasing authority. Page under review: AI Teams for Startups of 1–5 People.

    I would investigate further. The idea of AI teammates for product, growth, and operations is intriguing, especially for a lean team like ours. However, the primary unanswered question is how these AI agents would integrate with our regulated product development process. Ensuring patient safety and regulatory compliance is paramount, and I need to understand the oversight and validation mechanisms for AI-driven work in this context. The cost of $199/month for one agent is noted, but the operational details for a medtech environment are the priority.
    View answer & full research →
  4. Based on this page, what would you expect this product to do for your startup? Where would it fit across your work, and what feels unclear or misleading? Page under review: AI Teams for Startups of 1–5 People.

    This product, Agent Teams, aims to provide AI teammates for startups of our size, focusing on product, growth, and operations. For us, it could potentially assist with product research and iteration, which is a significant part of my day. I'm curious about how well it can handle the specific, nuanced workflows we're analyzing in hospitals and if it can truly grasp the regulatory complexities. The idea of "AI teammates" is intriguing, but I need to understand the level of oversight required and how it integrates with our existing clinical data pilots. The cost starts at $199/month, which seems manageable, but the real value would be in demonstrable improvements to our development and validation processes.
    View answer & full research →
  5. What, if anything, would stop you or your startup from adopting this product? Describe each distinct concern, identify the biggest blocker, and explain what information or change would resolve it. Do not invent concerns if you have none. Page under review: One Founder, a Company of Agents.

    Our primary concern would be regulatory compliance and patient safety. While the concept of an AI team handling product, growth, and operations is intriguing, especially for a lean startup, integrating such a system into a regulated medtech environment requires extreme caution. The biggest blocker is ensuring these AI agents can consistently adhere to strict protocols and generate auditable, verifiable data suitable for regulatory bodies. We would need clear evidence of robust data security, error-handling mechanisms, and a framework for human oversight and intervention. Without this, the risks associated with patient care are too high.
    View answer & full research →
  6. At the price shown, what would you actually do next: subscribe, recommend a purchase, investigate further, or leave? Explain the main reason and the most important unanswered question. Consider your actual role and purchasing authority. Page under review: One Founder, a Company of Agents.

    I would investigate further. The concept of an AI team to handle product, growth, and operations is intriguing, especially given our lean team of three. However, my primary concern is how this integrates with a regulated software product. Ensuring data integrity and compliance within a medical device context is paramount, and I need to understand the level of control and validation possible with these agents. The most important unanswered question is the specific methodology for ensuring regulatory compliance and patient safety when using these AI agents for product development and operations.
    View answer & full research →
  7. Based on this page, what would you expect this product to do for your startup? Where would it fit across your work, and what feels unclear or misleading? Page under review: One Founder, a Company of Agents.

    This product, Agent Teams, presents an interesting proposition for a solo founder or a very small team like ours. The idea of AI agents handling product development, growth, and operations could, in theory, augment our capacity significantly. It might help with tasks like market research or initial product testing, freeing up my clinical co-founder and engineer. However, the notion of AI agents performing regulated product development for a medtech startup feels unclear and potentially misleading given the stringent requirements we face. Patient safety and data integrity are paramount; I'm skeptical about AI's current ability to navigate these complexities without human oversight, especially concerning regulatory compliance and clinical workflow analysis.
    View answer & full research →
Keep exploring

What would you ask next?

Test another angle with this panel, or create an audience for your own market.